A review of the role of fever in stimulating the immune system to fight infections and cancer.

OmniSeq, LLC today announced that it has officially begun its spin-out from Roswell Park Cancer Institute and will immediately begin commercializing its suite of innovative products that support a physician-driven, collaborative approach to genomic diagnostics — matching cancer patients to therapies tailored specifically to them.

A free Mindfulness Workshop is being offered to cancer patients, survivors and their caregivers and families during the Roswell Park Cancer Institute “Celebration of Hope” – an event that coincides with the Ride for Roswell.

Blood and Marrow Transplantation (BMT) is a potentially curative treatment for patients with leukemia or other life-threating blood diseases.

A study led by the University at Buffalo (UB) and Roswell Park Cancer Institute (RPCI) has identified beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients.

More than 150 news organizations from around the country have published stories about the award-winning research conducted by Roswell Park scientists and recently presented at the annual meeting of the American Society of Clinical Oncology.

Many teens with cancer are unable to attend their high school’s prom because of their diagnosis.

A large cooperative-group study directed by the Alliance for Clinical Trials in Oncology has confirmed previous evidence that the drug lenalidomide delays time to disease progression for patients with multiple myeloma and is an important treatment option for patients with this rare but increasingly common cancer of the blood and marrow.